14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Oct 29, 2019 $3.36 $3.41 $3.23 $3.30 70 027
Oct 28, 2019 $3.35 $3.47 $3.32 $3.37 37 752
Oct 25, 2019 $3.40 $3.46 $3.26 $3.30 20 244
Oct 24, 2019 $3.33 $3.42 $3.16 $3.39 25 672
Oct 23, 2019 $3.27 $3.35 $3.12 $3.29 37 368
Oct 22, 2019 $3.18 $3.28 $3.11 $3.22 36 495
Oct 21, 2019 $3.50 $3.50 $3.17 $3.20 47 816
Oct 18, 2019 $3.43 $3.50 $3.34 $3.39 18 354
Oct 17, 2019 $3.48 $3.54 $3.42 $3.47 32 505
Oct 16, 2019 $3.41 $3.54 $3.40 $3.44 22 877
Oct 15, 2019 $3.48 $3.53 $3.35 $3.47 42 351
Oct 14, 2019 $3.20 $3.69 $3.20 $3.42 114 025
Oct 11, 2019 $3.20 $3.20 $3.09 $3.12 23 721
Oct 10, 2019 $3.07 $3.13 $3.00 $3.10 22 369
Oct 09, 2019 $3.01 $3.26 $2.97 $2.99 31 210
Oct 08, 2019 $3.07 $3.11 $3.00 $3.01 46 487
Oct 07, 2019 $3.15 $3.33 $3.15 $3.16 12 455
Oct 04, 2019 $3.20 $3.20 $3.12 $3.15 22 475
Oct 03, 2019 $3.15 $3.27 $3.10 $3.17 23 029
Oct 02, 2019 $3.10 $3.19 $3.02 $3.17 48 727
Oct 01, 2019 $3.32 $3.48 $3.10 $3.11 28 091
Sep 30, 2019 $3.26 $3.42 $3.10 $3.29 59 681
Sep 27, 2019 $3.40 $3.40 $3.21 $3.27 23 175
Sep 26, 2019 $3.71 $3.71 $3.35 $3.37 44 526
Sep 25, 2019 $3.41 $3.75 $3.27 $3.73 89 531
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT